USD
$0.00
(0.00%
)At Close (As of Nov 5, 2025)
$2.98B
Market Cap
14.21
P/E Ratio
4.26
EPS
$90.04
52 Week High
$59.62
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $634M |
| Total Revenue | $1.1B |
| Cost Of Revenue | $503M |
| Costof Goods And Services Sold | $503M |
| Operating Income | $337M |
| Selling General And Administrative | $108M |
| Research And Development | - |
| Operating Expenses | $298M |
| Investment Income Net | - |
| Net Interest Income | -$48M |
| Interest Income | $48M |
| Interest Expense | $48M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $30M |
| Income Before Tax | $284M |
| Income Tax Expense | $70M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $215M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $332M |
| Ebitda | $362M |
| Net Income | $215M |
| Field | Value (USD) |
|---|---|
| Total Assets | $3.4B |
| Total Current Assets | $448M |
| Cash And Cash Equivalents At Carrying Value | $98M |
| Cash And Short Term Investments | $98M |
| Inventory | $148M |
| Current Net Receivables | $194M |
| Total Non Current Assets | $3B |
| Property Plant Equipment | $128M |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $2.3B |
| Intangible Assets Excluding Goodwill | $2.3B |
| Goodwill | $527M |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $8.4M |
| Other Non Current Assets | - |
| Total Liabilities | $1.6B |
| Total Current Liabilities | $107M |
| Current Accounts Payable | $19M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $8.5M |
| Total Non Current Liabilities | $1.5B |
| Capital Lease Obligations | $52M |
| Long Term Debt | $992M |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $1B |
| Other Current Liabilities | $78M |
| Other Non Current Liabilities | $5.4M |
| Total Shareholder Equity | $1.8B |
| Treasury Stock | - |
| Retained Earnings | $1.6B |
| Common Stock | $560K |
| Common Stock Shares Outstanding | $50M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $252M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $30M |
| Capital Expenditures | $8.2M |
| Change In Receivables | - |
| Change In Inventory | -$9.3M |
| Profit Loss | - |
| Cashflow From Investment | -$17M |
| Cashflow From Financing | -$182M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$52M |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $215M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $634M |
| Total Revenue | $1.1B |
| Cost Of Revenue | $503M |
| Costof Goods And Services Sold | $503M |
| Operating Income | $337M |
| Selling General And Administrative | $108M |
| Research And Development | - |
| Operating Expenses | $298M |
| Investment Income Net | - |
| Net Interest Income | -$48M |
| Interest Income | $48M |
| Interest Expense | $48M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $30M |
| Income Before Tax | $284M |
| Income Tax Expense | $70M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $215M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $332M |
| Ebitda | $362M |
| Net Income | $215M |
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Prestige Consumer Healthcare Inc. (Ticker: PBH) is a leading player in the over-the-counter (OTC) healthcare market, based in Tarrytown, New York. The company focuses on the development, manufacturing, marketing, and distribution of a comprehensive range of wellness-focused OTC products, catering to both domestic and international consumers. With a strong emphasis on innovation and quality, Prestige harnesses a diverse brand portfolio to address the growing consumer demand for health solutions. The company is strategically positioned for continued growth within the changing healthcare landscape, aiming to enhance consumer well-being while maximizing shareholder value through targeted expansion initiatives.